RI
Insider selling
Robert I Blum sold $491K of Cytokinetics Inc (CYTK) stock
Robert I Blum, President & CEO of Cytokinetics Inc (CYTK), sold 7,500 shares of CYTK stock worth $491K, per an SEC Form 4 filed Sep 28, 2026.
The sale was pre-arranged (a 10b5-1 plan or an option exercise), not a fresh decision.
The trade was reported on Sep 28, 2026.
CYTK has moved +0.0% since the trade date, from $66.16 to $66.16 (Sep 28, 2026 close).
- Traded
- Sep 28, 2026
- Disclosed
- Sep 28, 2026
- Filing delay
- 0 days
- Price since
- +0.0%
- Role
- President & CEO
- Source
- SEC Form 4
More CYTK insider and Congress trades
From a public SEC Form 4, linked above. Not investment advice, and not a recommendation to buy or sell.